Available Until 12/18/2026
View Cart

Recorded Pharmacist Educational Series: Platelet Factor 4

ACPE Activity Number: 0204-0000-24-173-H01-P
Release Date: December 18, 2024
Expiration Date: December 18 2026
Activity Type: Knowledge-based
CE Credits:  0.5 contact hours, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

Biomarkers, including Platelet Factor 4 (PF4) for HIT, have several roles for applicability, limitations, and emerging areas for use. These are important for pharmacists to know, understand, and utilize appropriately when they are caring for patients on heparin. This field has been steadily growing and would benefit from continuing education.

ACPE Provider with Commendation logo

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists who may use the Platelet Factor 4 biomarker for managing patients with Heparin Induced Thrombocytopenia.

After participating in this CPE activity, participants should be able to:

  • Select an appropriate testing strategy for heparin-induced thrombocytopenia (HIT).
  • Summarize the correct interpretation of a HIT test. 

  • Introduction and Announcements 

  • Presentation  

Jeremy Whitfield Vandiver
Clinical Associate Professor
University of Wyoming School of Pharmacy
Saint Joseph Hospital
Denver, CO 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.